| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $260.1M | -2.6% | +3.8% |
| Cost of Revenue | $102.6M | -3.2% | -1.8% |
| R&D Expense | $22.4M | +7.8% | -21.8% |
| SG&A Expense | $43.3M | -10.6% | -1.6% |
| Operating Income | $32.5M | -6.4% | +79.0% |
| Pre-tax Income | $31.4M | -27.2% | +79.2% |
| Income Tax | $18.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $165.5M | +42.2% | +26.0% |
| Accounts Receivable | $125.2M | -17.5% | +35.8% |
| Current Assets | $336.8M | +9.1% | +21.4% |
| Total Assets | $1.38B | -0.1% | +2.0% |
| Current Liabilities | $631.0M | -0.5% | -4.9% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $130.5M | — | — |
| Capital Expenditures | $32.5M | — | — |
| Investing Cash Flow | -$37.4M | — | — |
| Financing Cash Flow | -$46.3M | — | — |
| Free Cash Flow | $97.9M | — | — |
| +31.6% |
| — |
| Net Income | $13.4M | -54.5% | -24.0% |
| EPS (Basic) | $0.38 | -54.8% | -24.0% |
| EPS (Diluted) | $0.37 | -54.9% | -26.0% |
| $117.4M |
| -0.6% |
| -2.5% |
| Total Liabilities | $781.2M | -1.1% | -5.4% |
| Stockholders' Equity | $594.4M | +1.4% | +13.7% |